# Wallkill BioPharma Inc.: Form D filing

Wallkill BioPharma Inc., a biotechnology company in Wilmington, DE, filed a Form D with the SEC in 2018. The latest, on March 28, 2018, reports $207,513 sold of a $207,513 offering to 6 investors.

Find out what Wallkill BioPharma Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Wallkill%20BioPharma%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Wallkill%20BioPharma%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fwallkill-biopharma-inc-1735845)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Wallkill%20BioPharma%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Wallkill%20BioPharma%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fwallkill-biopharma-inc-1735845)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Delaware](https://specstream.ai/data/form-d/state/delaware): 1,342 rows, by operating companies, filed since November 1, 2024, $67.10, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/delaware
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1013 CENTRE ROAD, SUITE 403-B, Wilmington, DE, 19805
- Phone: (858) 900-1521
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2017
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1735845

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Mar 28, 2018 | New notice | $207,513 | $207,513 | $0 | 6 | Oct 22, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1735845/000173584518000001/0001735845-18-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| GERALD SWISS | Executive Officer, Director |  |
| MARTIN BELL | Executive Officer, Director |  |

## Other biotechnology companies in Delaware that filed recently

- [TCM Life Science Inc.](https://specstream.ai/data/form-d/company/tcm-life-science-inc-2160964) $16,666 · Oct 26, 2026
- [Amplica Bio, Inc.](https://specstream.ai/data/form-d/company/amplica-bio-inc-2154543) $30,000 · Sep 11, 2026

[Every Form D from the week of Mar 26, 2018](https://specstream.ai/data/form-d/week/2018-03-26) · [All recent filings in Delaware](https://specstream.ai/data/form-d/state/delaware) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Wallkill BioPharma Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).